Materias dentro de su búsqueda.
Mostrando 1 - 20 Resultados de 102 Para Buscar 'Canadian Agency for Drugs and Technologies in Health', tiempo de consulta: 0.08s Limitar resultados
  1. 1
    Clinical review report : (Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange (PEX) and immunosuppress
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  2. 2
    Pharmacoeconomic Review Report : Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  3. 3
    Pharmacoeconomic Review Report : Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  4. 4
    Monitoring for atrial fibrillation in discharged stroke and transient ischemic attack patients : a clinical and cost-effectiveness analysis and review of patient preferences
    Publicado 2016
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  5. 5
    CADTH issues in emerging health technologies
    “…Canadian Agency for Drugs and Technologies in Health…”
    Revista digital
  6. 6
    CADTH health technology review
    “…Canadian Agency for Drugs and Technologies in Health…”
    Revista digital
  7. 7
    Point-of-care troponin testing in patients with symptoms suggestive of acute coronary syndrome Recommendations
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  8. 8
    Pharmacoeconomic review report Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on behalf of Icon Canada Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  9. 9
    Pharmacoeconomic review report Tocilizumab (Actemra) (Hoffman-La Roche Limited)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  10. 10
    Pharmacoeconomic review report Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  11. 11
    Pharmacoeconomic review report Tiotropium bromide monohydrate (Spiriva respimat) for inhalation
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  12. 12
    Pharmacoeconomic review report : Tenofovir alafenamide (Vemlidy) (Gilead Sciences Canada, Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  13. 13
    Pharmacoeconomic review report : Tapentadol hydrochloride extended-release tablet (Nucynta extended-release) (Paladin Labs Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  14. 14
    Pharmacoeconomic review report : Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  15. 15
    Pharmacoeconomic review report : Sapropterin dihydrochloride (Kuvan)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  16. 16
    Pharmacoeconomic review report : Risankizumab (Skyrizi) (AbbVie)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  17. 17
    Pharmacoeconomic review report : Riociguat (Adempas)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  18. 18
    Pharmacoeconomic review report : Propiverine hydrochloride (Mictoryl/Mictoryl pediatric)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  19. 19
    Pharmacoeconomic review report : Nusinersen (Spinraza) (Biogen Canada Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  20. 20
    Pharmacoeconomic review report : Nitisinone (MDK-Nitisinone) (MendeliKABS inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico

Herramientas de búsqueda: